141 related articles for article (PubMed ID: 38183507)
21. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
22. Free fatty acids induce the demethylation of the fructose 1,6-biphosphatase 2 gene promoter and potentiate its expression in hepatocytes.
Wang L; Liu M; Wu Y; Li X; Yin F; Yin L; Liu J
Food Funct; 2021 May; 12(9):4165-4175. PubMed ID: 33977939
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
25. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
27. The promoter aberrant methylation status of TMEM130 is associated with gastric cancer.
Zhang Y; Hu S; Li J; Shi D; Luo B
Dig Liver Dis; 2022 Jun; 54(6):819-825. PubMed ID: 34162508
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.
Zhu YZ; Zhu R; Shi LG; Mao Y; Zheng GJ; Chen Q; Zhu HG
Exp Mol Pathol; 2010 Dec; 89(3):268-75. PubMed ID: 20620135
[TBL] [Abstract][Full Text] [Related]
29. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
Geddert H; Zur Hausen A; Gabbert HE; Sarbia M
Anal Cell Pathol (Amst); 2010; 33(3):143-9. PubMed ID: 20978327
[TBL] [Abstract][Full Text] [Related]
30. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
[TBL] [Abstract][Full Text] [Related]
31. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684
[TBL] [Abstract][Full Text] [Related]
32. Fructose-1,6-bisphosphatase 2 represses cervical cancer progression via inhibiting aerobic glycolysis through promoting pyruvate kinase isozyme type M2 ubiquitination.
Wang B; Yuan Y; Zou Y; Qi Z; Huang G; Liu Y; Xia S; Huang Y; Huang Z
Anticancer Drugs; 2022 Jan; 33(1):e198-e206. PubMed ID: 34387592
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development.
Zhang BG; Hu L; Zang MD; Wang HX; Zhao W; Li JF; Su LP; Shao Z; Zhao X; Zhu ZG; Yan M; Liu B
Oncotarget; 2016 Mar; 7(9):9788-800. PubMed ID: 26848521
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E
Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
[No Abstract] [Full Text] [Related]
35. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.
Yuan X; Xu J; Fang W; Zhao Z; Wang F; Tong Z
Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044
[TBL] [Abstract][Full Text] [Related]
36. Fructose bisphosphatase 2 overexpression increases glucose uptake in skeletal muscle.
Bakshi I; Suryana E; Small L; Quek LE; Brandon AE; Turner N; Cooney GJ
J Endocrinol; 2018 May; 237(2):101-111. PubMed ID: 29507044
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
38. DNMT3A rs36012910 A>G polymorphism and gastric cancer susceptibility in a Chinese population.
Wu Q; Lu S; Wang L; Hu J; Qiao F; Qiu X; Zhao C; Lao Y; Song Y; Fan H
Mol Biol Rep; 2012 Dec; 39(12):10949-55. PubMed ID: 23053986
[TBL] [Abstract][Full Text] [Related]
39. Promoter Hypermethylation and Its Impact on Expression of MGMT Gene in the GIT Malignant Patients of Kashmiri Origin.
Bhat AA; Wani HA; Ishaq S; Waza AA; Malik RA; Shabir I; Jeelani S; Kadla S; Qureshie W; Masood A; Majid S
Cancer Invest; 2017 Feb; 35(2):116-121. PubMed ID: 28135856
[TBL] [Abstract][Full Text] [Related]
40. RNautophagic regulation of DNMT3a-dependent DNA methylation by Linc00942 enhances chemoresistance in gastric cancer.
Zhu L; Zhu Y; Li F; Meng Y; Wang H; Xu W; Luo J; Wang X; Feng L; Jin H
Clin Transl Med; 2023 Jul; 13(7):e1337. PubMed ID: 37477089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
